Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1994 Mar;38(3):588–593. doi: 10.1128/aac.38.3.588

Tuftsin-bearing liposomes as rifampin vehicles in treatment of tuberculosis in mice.

A Agarwal 1, H Kandpal 1, H P Gupta 1, N B Singh 1, C M Gupta 1
PMCID: PMC284502  PMID: 8203859

Abstract

The antitubercular activity of rifampin was considerably increased when it was encapsulated in egg phosphatidylcholine liposomes. A further increase in the activity was observed when the macrophage activator tetrapeptide tuftsin was grafted on the surface of the drug-loaded liposomes. Intermittent treatments (twice weekly) with these preparations were significantly more effective than the continuous treatments. Rifampin delivered twice weekly for 2 weeks in tuftsin-bearing liposomes was at least 2,000 times more effective than the free drug in lowering the load of lung bacilli in infected animals. However, pretreatment with drug-free tuftsin-bearing liposomes did not render the pretreated animals resistant to the Mycobacterium tuberculosis infections, neither did it appreciably increase the chemotherapeutic efficacy of the liposomized rifampin. These results clearly demonstrate that liposome targeting to macrophages could considerably increase the antitubercular activity of liposomized drugs such as rifampin. Also, it shows that immunoprophylactic treatment with macrophage activators such as tuftsin does not afford any advantage in treatment of tuberculosis infections, presumably because of inactivation of the primed macrophages by the mycobacterial sulfatides.

Full text

PDF
588

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alving C. R. Liposomes as drug carriers in leishmaniasis and malaria. Parasitol Today. 1986 Apr;2(4):101–107. doi: 10.1016/0169-4758(86)90039-6. [DOI] [PubMed] [Google Scholar]
  2. GUPTA S. K., CHAKRAVARTI R. N. The therapeutic activity of some sulphones and sulphoxides in experimental tuberculosis of guinea-pigs. Br J Pharmacol Chemother. 1955 Mar;10(1):113–115. doi: 10.1111/j.1476-5381.1955.tb00068.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Girling D. J. The hepatic toxicity of antituberculosis regimens containing isoniazid, rifampicin and pyrazinamide. Tubercle. 1978 Mar;59(1):13–32. doi: 10.1016/0041-3879(77)90022-8. [DOI] [PubMed] [Google Scholar]
  4. Gupta C. M., Puri A., Jain R. K., Bali A., Anand N. Protection of mice against Plasmodium berghei infection by a tuftsin derivative. FEBS Lett. 1986 Sep 15;205(2):351–354. doi: 10.1016/0014-5793(86)80927-9. [DOI] [PubMed] [Google Scholar]
  5. Guru P. Y., Agrawal A. K., Singha U. K., Singhal A., Gupta C. M. Drug targeting in Leishmania donovani infections using tuftsin-bearing liposomes as drug vehicles. FEBS Lett. 1989 Mar 13;245(1-2):204–208. doi: 10.1016/0014-5793(89)80222-4. [DOI] [PubMed] [Google Scholar]
  6. Orozco L. C., Forero M., Wasserman M., Ahumada J. J. Distribution of liposomes in tuberculous mice. Tubercle. 1990 Sep;71(3):209–214. doi: 10.1016/0041-3879(90)90078-m. [DOI] [PubMed] [Google Scholar]
  7. Orozco L. C., Quintana F. O., Beltrán R. M., de Moreno I., Wasserman M., Rodriguez G. The use of rifampicin and isoniazid entrapped in liposomes for the treatment of Murine tuberculosis. Tubercle. 1986 Jun;67(2):91–97. doi: 10.1016/0041-3879(86)90002-4. [DOI] [PubMed] [Google Scholar]
  8. Owais M., Ahmed I., Krishnakumar B., Jain R. K., Bachhawat B. K., Gupta C. M. Tuftsin-bearing liposomes as drug vehicles in the treatment of experimental aspergillosis. FEBS Lett. 1993 Jul 12;326(1-3):56–58. doi: 10.1016/0014-5793(93)81760-w. [DOI] [PubMed] [Google Scholar]
  9. Pabst M. J., Gross J. M., Brozna J. P., Goren M. B. Inhibition of macrophage priming by sulfatide from Mycobacterium tuberculosis. J Immunol. 1988 Jan 15;140(2):634–640. [PubMed] [Google Scholar]
  10. Raleigh J. W. Rifampin in treatment of advanced pulmonary tuberculosis. Report of a VA cooperative pilot study. Am Rev Respir Dis. 1972 Mar;105(3):397–409. doi: 10.1164/arrd.1972.105.3.397. [DOI] [PubMed] [Google Scholar]
  11. SINGLETON W. S., GRAY M. S., BROWN M. L., WHITE J. L. CHROMATOGRAPHICALLY HOMOGENEOUS LECITHIN FROM EGG PHOSPHOLIPIDS. J Am Oil Chem Soc. 1965 Jan;42:53–56. doi: 10.1007/BF02558256. [DOI] [PubMed] [Google Scholar]
  12. Singh S. P., Chhabra R., Srivastava V. M. Respiratory burst in peritoneal exudate cells in response to a modified tuftsin. Experientia. 1992 Oct 15;48(10):994–996. doi: 10.1007/BF01919150. [DOI] [PubMed] [Google Scholar]
  13. Singhal A., Bali A., Jain R. K., Gupta C. M. Specific interactions of liposomes with PMN leukocytes upon incorporating tuftsin in their bilayers. FEBS Lett. 1984 Dec 3;178(1):109–113. doi: 10.1016/0014-5793(84)81251-x. [DOI] [PubMed] [Google Scholar]
  14. Tuberculosis and leprosy. Br Med Bull. 1988 Jul;44(3):523–820. [PubMed] [Google Scholar]
  15. Zierski M., Bek E. Side-effects of drug regimens used in short-course chemotherapy for pulmonary tuberculosis. A controlled clinical study. Tubercle. 1980 Mar;61(1):41–49. doi: 10.1016/0041-3879(80)90060-4. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES